Literature DB >> 25802348

Case report of GNAS epigenetic defect revealed by a congenital hypothyroidism.

Pauline Romanet1, Lindsay Osei2, Irène Netchine3, Morgane Pertuit4, Alain Enjalbert1, Rachel Reynaud5, Anne Barlier6.   

Abstract

Pseudohypoparathyroidism (PHP) is a group of disorders characterized by end-organ resistance to the parathyroid hormone (PTH). PHP type 1A includes multihormone resistance syndrome, Albright's hereditary osteodystrophy, and obesity and is caused by mutations in GNAS exon 1 through 13. PHP type 1B (PHP1B), caused by epigenetic changes in the GNAS locus, was initially described as an isolated resistance to PTH. Epigenetic changes in GNAS have also been reported in patients who display mild Albright's hereditary osteodystrophy or mild thyroid-stimulating hormone (TSH) resistance without mutation of GNAS. Here we report a case of PHP caused by epigenetic changes in GNAS in a patient with congenital hypothyroidism. The patient was referred for a positive newborn screening for hypothyroidism (TSH 50 mIU/L). She exhibited severe clinical features of congenital hypothyroidism. The thyroid was in place, and etiologic explorations were negative. TSH was normalized under L-thyroxin, and the symptoms disappeared, except for a macroglossia. In childhood, PHP was suspected in addition to elevated PTH, obesity, brachydactyly, and a rounded face. Sequencing, methylation analysis, and large deletion research were performed in GNAS. No genetic mutations were found. Methylation analysis revealed a broad epigenetic defect without deletion in GNAS consistent with sporadic PHP1B. The multilocus methylation analysis were negative. This finding expands the known onsets of PHP1B and emphasizes the need for a new PHP classification system. This case report has important consequences for the etiologic diagnosis of congenital hypothyroidism because it adds a new cause of the disease.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Keywords:  GNAS; TSH resistance; congenital hypothyroidism; epigenetic; imprinting disorder; pseudohypoparathyroidism type 1B

Mesh:

Substances:

Year:  2015        PMID: 25802348     DOI: 10.1542/peds.2014-2806

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

Review 2.  Nonclassic features of pseudohypoparathyroidism type 1A.

Authors:  Ashley H Shoemaker; Harald Jüppner
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

3.  Mice maintain predominantly maternal Gαs expression throughout life in brown fat tissue (BAT), but not other tissues.

Authors:  Olta Tafaj; Steven Hann; Ugur Ayturk; Matthew L Warman; Harald Jüppner
Journal:  Bone       Date:  2017-07-08       Impact factor: 4.398

4.  Pseudohypoparathyroidism type 1B caused by methylation changes at the GNAS complex locus.

Authors:  Sabrina Poradosu; Bert Bravenboer; Rieko Takatani; Harald Jüppner
Journal:  BMJ Case Rep       Date:  2016-05-11

5.  Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes.

Authors:  Annette Grüters-Kieslich; Monica Reyes; Amita Sharma; Cem Demirci; Terry J DeClue; Erwin Lankes; Dov Tiosano; Dirk Schnabel; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

6.  Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.

Authors:  Patrick Hanna; Virginie Grybek; Guiomar Perez de Nanclares; Léa C Tran; Luisa de Sanctis; Francesca Elli; Javier Errea; Bruno Francou; Peter Kamenicky; Léa Linglart; Arrate Pereda; Anya Rothenbuhler; Daniele Tessaris; Susanne Thiele; Alessia Usardi; Ashley H Shoemaker; Marie-Laure Kottler; Harald Jüppner; Giovanna Mantovani; Agnès Linglart
Journal:  J Bone Miner Res       Date:  2018-06-07       Impact factor: 6.741

Review 7.  Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.

Authors:  Serap Turan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-12-27

Review 8.  Pseudohypoparathyroidism, acrodysostosis, progressive osseous heteroplasia: different names for the same spectrum of diseases?

Authors:  Francesca Marta Elli; Giovanna Mantovani
Journal:  Endocrine       Date:  2020-11-11       Impact factor: 3.633

9.  Next-Generation Sequencing Analysis Reveals Frequent Familial Origin and Oligogenism in Congenital Hypothyroidism With Dyshormonogenesis.

Authors:  Isabelle Oliver-Petit; Thomas Edouard; Virginie Jacques; Marie Bournez; Audrey Cartault; Solange Grunenwald; Frédérique Savagner
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

10.  Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects.

Authors:  Anne Rochtus; Alejandro Martin-Trujillo; Benedetta Izzi; Francesca Elli; Intza Garin; Agnes Linglart; Giovanna Mantovani; Guiomar Perez de Nanclares; Suzanne Thiele; Brigitte Decallonne; Chris Van Geet; David Monk; Kathleen Freson
Journal:  Clin Epigenetics       Date:  2016-01-26       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.